DOCSLIB.ORG

Dengue and Chikungunya Fever)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dengue and Chikungunya Fever) Br Heart J: first published as 10.1136/hrt.34.8.821 on 1 August 1972. Downloaded from British HeartJournal, I972, 34, 82I-827. Myocarditis and cardiomyopathy after arbovirus infections (dengue and chikungunya fever) Ivor Obeyesekere and Yvette Hermon From the Cardiology Unit, General Hospital, Colombo, and the Virus Laboratory, Medical Research Institute, Colombo, Ceylon The varying clinicalfeatures and sequelae in Io patients sufferingfrom myocarditis after dengue and chikungunya fever caused by arboviruses are described. These patients had significantly raised antibody levels in the serum and gave a recent history of 'dengue-like' fever. Afew patients had afavourable outcome with disappearance ofsymptoms, improvement in the electrocardiogram, and no residual cardiomegaly. Others had persistent symptoms, electrocardio- graphic changes, and cardiomegaly which suggested a transition to cardiomyopathy, a chronic cardiac disorder. It seems likely that arbovirus infections play a significant role in the aetiology of the cardiomyopathies which are common in Ceylon. Myocarditis or inflammation of the myocar- rhythm; (3) a recent history of 'dengue-like' dium refers to myocardial lesions and symp- fever; (4) serological evidence of past dengue or toms associated with infectious diseases and chikungunya infection as revealed by the presence specific infections. Among the reported causes of antibody in high titre. are The study included the history, physical bacterial, viral, mycotic, protozoal and examination, serial electrocardiograms, serial x- Rickettsial infections, parasitic infestations, rays of chest, and cardiac catheterization in two http://heart.bmj.com/ and specific bacterial toxins. Of the viruses, patients. The laboratory tests included routine Coxsackie B, and less frequently viruses examination of urine and blood, estimation of causing infectious mononucleosis, infectious transaminases, erythrocyte sedimentation rates, hepatitis, mumps, measles, poliomyelitis, complement-fixation tests for toxoplasmosis and aseptic meningitis, and encephalo-myocar- filariasis, antistreptolysin titres, and tests for ditis have been reported to be pathogenic to systemic lupus erythematosus. man. While dengue and chikungunya fever Serological tests for arbovirus antibody were carried out by means of the haemagglutination- are well recognized, there are very few on September 30, 2021 by guest. Protected copyright. pub- inhibition test to determine evidence of past lished reports concerning their cardiac com- arbovirus infection. Simultaneously, the same plications (Boon and Tan, I967; Hyman, test was carried out on 3 control groups ofpatients I943). Myocarditis, which was thought to be also admitted to the Cardiology Unit, (I) those benign, is now known to lead to a more with rheumatic heart disease, (2) those suffering chronic disorder, cardiomyopathy (Bengtsson, from coronary heart disease, with characteristic I968). electrocardiographic changes and transient rises This paper describes the varying clinical in activity of serum enzymes (SGOT), and (3) features and sequelae of patients suffering those with congenital heart disease. The comple- from myocarditis in association with dengue ment-fixation test was done on IO patients suffer- and chikungunya fever caused ing from myocarditis who showed high haemag- by arboviruses glutination-inhibition antibody levels. The de- and referred to as 'arbovirus myocarditis'. scription of the antigens used and serological techniques are described in the Appendix. Subjects and methods For the purpose of this study io patients were Results selected in whom a diagnosis of arbovirus myo- The results of haemagglutination-inhibition carditis was made. The following diagnostic and complement-fixation tests in IO patients criteria were used. (i) Clinical evidence of myo- with myocarditis are given in Table carditis; (2) the presence of electrocardiographic i. All evidence of myocarditis, ST segment and T wave these (except Case 9) had haemagglutination- changes, and disturbances in conduction and inhibition antibody levels of i: 640 or greater to either dengue (Type I or II) or chikun- Received 25 October 1971. gunya, and all (except Case i) had comple- Br Heart J: first published as 10.1136/hrt.34.8.821 on 1 August 1972. Downloaded from 822 Obeyesekere and Hermon TABLE I Virus serological results ofpatients with acute arbovirus myocarditis Case Age Sex Haemagglutination inhibition titre Complement-fixation titre No. JE DI D2 Chik JE Di D2 Chik I 43 F < 20 640 I60 I280 <4 I6 i6 32 2 24 F i6o 640 640 <20 <4 64 32 < 4 3 33 F 640 2560 i28o <20 32 I28 64 <4 4 48 F 320 320 640 <20 8 I28 i28 <4 5 32 F 320 640 640 <20 i6 64 64 <4 6 44 F 8o 80 80 2560 <4 8 i6 I28 7 5I M I60 640 640 <20 8 64 64 <4 8 20 F I60 I280 i6o <20 8 I28 32 < 4 9 40 M 320 320 320 I60 8 64 I28 i6 o0 5 F 320 640 640 <20 8 64 64 4 II I8 F < 20 8o 80 5I20 I2 54 F 40 i6o I60 640 l 13 36 M I60 320 i60 40 l I4 48 F 40 320 i60 I60 i6I6 3653° FM i68o80 640320 320 <20 Not done 17 i8 F 40 320 i60 40 I8 7 M <20 320 40 <20 I9 32 F i6o i6o 320 <20 20 59 M < 20 i6o 8o 320 ment-fixation antibody levels of I: 64 or past arbovirus infection. It is postulated that greater. Ten other patients with myocarditis dengue and chikungunya fevers, with their had haemagglutination-inhibition titres of prominent myalgic manifestations, involved I:320 and above to dengue or chikungunya. the myocardium and triggered off the chain Table 2 gives the haemagglutination-inhibi- of symptoms resulting in acute myocarditis tion and complement-fixation test results in followed, in some cases, by cardiomyopathy. the 3 control groups. There was a striking and All the I0 patients with acute myocarditis http://heart.bmj.com/ highly significant difference, with only one gave a history of 'dengue-like' illness in the patient with a haemagglutination-inhibition recent or distant past. It was not possible by titre of I: 320 and two with titres of i: i6o. determining the haemagglutination-inhibition A serological diagnosis of arbovirus infec- antibody levels of single sera to determine tion necessarily depends on the examination whether the infections were primary or secon- of paired sera, the first sample being collected dary dengue. However, the complement- in the acute phase and the second convalescent fixation test results confirmed that all these sample 2 or 3 weeks later. The criteria for were secondary or recurrent infections as on September 30, 2021 by guest. Protected copyright. serological diagnosis have been described there was antibody to both Types I and II (Nimmannitya et al., I969). Primary and dengue. Two patients (Cases i and 6) showed secondary or recurrent infection are recog- high haemagglutination-inhibition and com- nized according to the haemagglutination- plement-fixation titres to chikungunya as well inhibition and complement-fixation antibody as dengue haemagglutination-inhibition and responses. In the I0 patients described in this complement-fixation antibody, which indi- paper, a diagnosis of acute arbovirus infection cated infections with both viruses in the past. was not initially sought. By the time these The main clinical features and sequelae of I0 patients presented themselves at the cardi- patients with arbovirus myocarditis are illus- ology unit they already had established cardiac trated by case histories. disorders which followed recent 'dengue-like' illnesses. Five of these patients (Cases I, 5, 6, 7, and 8) also gave definite histories of Case histories similar attacks of fever occurring months or Case I A 43-year-old housewife developed years earlier. Only evidence of past arbovirus sharp pain over the praecordium, difficulty in infection was, therefore, sought and a single taking a deep breath, profuse sweating, and of was dizziness. sample blood sent for detection of A few days previously and also three months arbovirus antibody. The results revealed that before she had had fever with recurrent head- all these patients had high dengue and chikun- aches, backache, and pains in the joints. gunya haemagglutination-inhibition and com- On examination, temperature was 37 40C, pulse plement-fixation antibody which confirmed a rate 78 a minute with frequent ectopics, and Br Heart J: first published as 10.1136/hrt.34.8.821 on 1 August 1972. Downloaded from Myocarditis and cardiomyopathy after arbovirus infections (dengue and chikungunya fever) 823 blood pressure 130/70 mmHg. Both heart sounds TABLE 2 Virus serological results ofpatients were heard. Crepitations were heard at the base with (a) rheumatic heart disease, (b) coronary of the left lung. She ran a low temperature for heart disease, and (c) congenital heart disease five days and complained of extreme fatigue and (controls) breathlessness. The ventricular ectopics persisted for four weeks. Disease Control Age Sex Haemagglutination inhibition titre Two months later, she was symptom free; No. there were no abnormal physical signs in the J7E Di D2 Chik heart. I 20 F < 20 8o < 20 < 20 Comments 2 I2 F < 20 < 20 < 20 < 20 3 I0 F <20 <20 <20 <20 This woman presented with severe chest pain 4 41 F < 20 8o 40 < 20 simulating coronary heart disease. She had ex- Rheumatic 5 10 F < 20 < 20 < 20 < 20 tensive electrocardiographic changes, a raised heut 6 24 F < 20 < 20 < 20 < 20 erythrocyte sedimentation rate, normal serum disease (12) 7 17 F < 20 < 20 < 20 < 20 enzymes, and positive serology for arbovirus in- 8 33 F <20 <20 <20 <20 fection. The pain was probably pericardial in 9 22 M < 20 < 20 < 20 < 20 I0 I9 M 40 320 320 < 20 origin. She made a satisfactory recovery within II 26 F < 20 < 20 < 20 < 20 two months with no symptoms, return of the I2 I7 F < 20 8o 40 < 20 electrocardiogram to normal, and no residual cardiomegaly. (13 45 M <20 <20 <20 <20 114 48 M <20 <20 <20 <20 I5 45 M 8o 40 8o <20 Case 2 An unmarried woman aged 24 years Coronary heart J I6 48 M 8o i6o 8o <20 presented with fever of I0 days' duration, general- disease (8) 17 57 F 8o 8o i6o i6o ized aches and pains, painful joints, palpitations, i8 44 M <20 <20 <20 <20 and sharp pain over the praecordium made worse I9 45 M <20 <20 <20 <20 by deep breathing.
Load more

Recommended publications
  • Cardiac Involvement in COVID-19 Patients: a Contemporary Review
    Review Cardiac Involvement in COVID-19 Patients: A Contemporary Review Domenico Maria Carretta 1, Aline Maria Silva 2, Donato D’Agostino 2, Skender Topi 3, Roberto Lovero 4, Ioannis Alexandros Charitos 5,*, Angelika Elzbieta Wegierska 6, Monica Montagnani 7,† and Luigi Santacroce 6,*,† 1 AOU Policlinico Consorziale di Bari-Ospedale Giovanni XXIII, Coronary Unit and Electrophysiology/Pacing Unit, Cardio-Thoracic Department, Policlinico University Hospital of Bari, 70124 Bari, Italy; [email protected] 2 AOU Policlinico Consorziale di Bari-Ospedale Giovanni XXIII, Cardiac Surgery, Policlinico University Hospital of Bari, 70124 Bari, Italy; [email protected] (A.M.S.); [email protected] (D.D.) 3 Department of Clinical Disciplines, School of Technical Medical Sciences, University of Elbasan “A. Xhuvani”, 3001 Elbasan, Albania; [email protected] 4 AOU Policlinico Consorziale di Bari-Ospedale Giovanni XXIII, Clinical Pathology Unit, Policlinico University Hospital of Bari, 70124 Bari, Italy; [email protected] 5 Emergency/Urgent Department, National Poisoning Center, Riuniti University Hospital of Foggia, 71122 Foggia, Italy 6 Department of Interdisciplinary Medicine, Microbiology and Virology Unit, University of Bari “Aldo Moro”, Piazza G. Cesare, 11, 70124 Bari, Italy; [email protected] 7 Department of Biomedical Sciences and Human Oncology—Section of Pharmacology, School of Medicine, University of Bari “Aldo Moro”, Policlinico University Hospital of Bari, p.zza G. Cesare 11, 70124 Bari, Italy; [email protected] * Correspondence: [email protected] (I.A.C.); [email protected] (L.S.) † These authors equally contributed as co-last authors. Citation: Carretta, D.M.; Silva, A.M.; D’Agostino, D.; Topi, S.; Lovero, R.; Charitos, I.A.; Wegierska, A.E.; Abstract: Background: The widely variable clinical manifestations of SARS-CoV2 disease (COVID-19) Montagnani, M.; Santacroce, L.
    [Show full text]
  • Myocarditis and Cardiomyopathy
    CE: Tripti; HCO/330310; Total nos of Pages: 6; HCO 330310 REVIEW CURRENT OPINION Myocarditis and cardiomyopathy Jonathan Buggey and Chantal A. ElAmm Purpose of review The aim of this study is to summarize the literature describing the pathogenesis, diagnosis and management of cardiomyopathy related to myocarditis. Recent findings Myocarditis has a variety of causes and a heterogeneous clinical presentation with potentially life- threatening complications. About one-third of patients will develop a dilated cardiomyopathy and the pathogenesis is a multiphase, mutlicompartment process that involves immune activation, including innate immune system triggered proinflammatory cytokines and autoantibodies. In recent years, diagnosis has been aided by advancements in cardiac MRI, and in particular T1 and T2 mapping sequences. In certain clinical situations, endomyocardial biopsy (EMB) should be performed, with consideration of left ventricular sampling, for an accurate diagnosis that may aid treatment and prognostication. Summary Although overall myocarditis accounts for a minority of cardiomyopathy and heart failure presentations, the clinical presentation is variable and the pathophysiology of myocardial damage is unique. Cardiac MRI has significantly improved diagnostic abilities, but endomyocardial biopsy remains the gold standard. However, current treatment strategies are still focused on routine heart failure pharmacotherapies and supportive care or cardiac transplantation/mechanical support for those with end-stage heart failure. Keywords cardiac MRI, cardiomyopathy, endomyocardial biopsy, myocarditis INTRODUCTION prevalence seen in children and young adults aged Myocarditis refers to inflammation of the myocar- 20–30 years [1]. dium and may be caused by infectious agents, systemic diseases, drugs and toxins, with viral infec- CAUSE tions remaining the most common cause in the developed countries [1].
    [Show full text]
  • Myocarditis, Pericarditis and Other Pericardial Diseases
    Heart 2000;84:449–454 Diagnosis is easiest during epidemics of cox- GENERAL CARDIOLOGY sackie infections but diYcult in isolated cases. Heart: first published as 10.1136/heart.84.4.449 on 1 October 2000. Downloaded from These are not seen by cardiologists unless they develop arrhythmia, collapse or suVer chest Myocarditis, pericarditis and other pain, the majority being dealt with in the primary care system. pericardial diseases Acute onset of chest pain is usual and may mimic myocardial infarction or be associated 449 Celia M Oakley with pericarditis. Arrhythmias or conduction Imperial College School of Medicine, Hammersmith Hospital, disturbances may be life threatening despite London, UK only mild focal injury, whereas more wide- spread inflammation is necessary before car- diac dysfunction is suYcient to cause symp- his article discusses the diagnosis and toms. management of myocarditis and peri- Tcarditis (both acute and recurrent), as Investigations well as other pericardial diseases. The ECG may show sinus tachycardia, focal or generalised abnormality, ST segment eleva- tion, fascicular blocks or atrioventricular con- Myocarditis duction disturbances. Although the ECG abnormalities are non-specific, the ECG has Myocarditis is the term used to indicate acute the virtue of drawing attention to the heart and infective, toxic or autoimmune inflammation of leading to echocardiographic and other investi- the heart. Reversible toxic myocarditis occurs gations. Echocardiography may reveal segmen- in diphtheria and sometimes in infective endo-
    [Show full text]
  • Myocarditis and Mrna Vaccines
    Updated June 28, 2021 DOH 348-828 Information for Clinical Staff: Myocarditis and mRNA Vaccines This document helps clinicians understand myocarditis and its probable link to some COVID-19 vaccines. It provides talking points clinicians can use when discussing the benefits and risks of these vaccines with their patients and offers guidance on what to do if they have a patient who presents with myocarditis following vaccination. Myocarditis information What are myocarditis and pericarditis? • Myocarditis is an inflammation of the heart muscle. • Pericarditis is an inflammation of the heart muscle covering. • The body’s immune system can cause inflammation often in response to an infection. The body’s immune system can cause inflammation after other things as well. What is the connection to COVID-19 vaccination? • A CDC safety panel has determined there is a “probable association” between myocarditis and pericarditis and the mRNA COVID-19 vaccines, made by Moderna and Pfizer-BioNTech, in some vaccine recipients. • Reports of myocarditis and pericarditis after vaccination are rare. • Cases have mostly occurred in adolescents and young adults under the age of 30 years and mostly in males. • Most patients who developed myocarditis after vaccination responded well to rest and minimal treatment. Talking Points for Clinicians The risk of myocarditis is low, especially compared to the strong benefits of vaccination. • Hundreds of millions of vaccine doses have safely been given to people in the U.S. To request this document in another format, call 1-800-525-0127. Deaf or hard of hearing customers, please call 711 (Washington Relay) or email [email protected].
    [Show full text]
  • Mitral Valve Disease in Dogs- Truly Epic Kristin Jacob, DVM, DACVIM CVCA Cardiac Care for Pets Towson, MD
    Mitral Valve Disease in Dogs- Truly Epic Kristin Jacob, DVM, DACVIM CVCA Cardiac Care for Pets Towson, MD Chronic degenerative mitral valvular disease (DMVD) is the most common heart disease in dogs. In dogs with congestive heart failure, 75% have mitral regurgitation/degenerative valvular disease. Almost all have tricuspid regurgitations as well, but clinically the mitral regurgitation is the most significant. Degenerative valvular disease is most common in small breed dogs and more common in males than females. DMVD has been proven to be inherited in the Cavalier King Charles Spaniel and the Dachshund but several other breeds are predisposed, such as Bichons, poodles, Chihuahuas, Miniature Schnauzers, Boston Terriers. The cause of degenerative valvular disease remains unknown. However, the valve changes occur due to a destruction of collagen, deposition of mucopolysaccharide in the spongiosa and fibrosa layer of mitral valve, which also affects chordae tendinea. These changes prevent effective coaptation of the valve leaflets leading to progressive mitral regurgitation. Mitral regurgitation (MR) leads to decreasing forward output and increasing left atrial and left ventricular dilation and remodeling as well as activation of the neurohormonal systems. Typically, patients will have 2-3 years in asymptomatic phase (time between when heart murmur detected) until symptoms develop - congestive heart failure (CHF). We can detect progressive heart enlargement 6-12 months prior to the development of CHF. This means that we have a fairly long time period to intervene with therapy and alter the progression of the disease - we know what’s coming! Eventually left atrial pressure increases sufficiently and pulmonary congestion develops leading to symptoms of CHF and can also lead to pulmonary hypertension.
    [Show full text]
  • Clinical Manifestation and Survival of Patients with I Diopathic Bilateral
    ORIGINAL ARTICLE Clinical Manifestation and Survival of Patients with Mizuhiro Arima, TatsujiI diopathicKanoh, Shinya BilateralOkazaki, YoshitakaAtrialIwama,DilatationAkira Yamasaki and Sigeru Matsuda Westudied the histories of eight patients who lacked clear evidence of cardiac abnormalities other than marked bilateral atrial dilatation and atrial fibrillation, which have rarely been dis- cussed in the literature. From the time of their first visit to our hospital, the patients' chest radio- graphs and electrocardiograms showed markedly enlarged cardiac silhouettes and atrial fibrilla- tion, respectively. Each patient's echocardiogram showed a marked bilateral atrial dilatation with almost normal wall motion of both ventricles. In one patient, inflammatory change was demonstrated by cardiac catheterization and endomyocardial biopsy from the right ventricle. Seven of our eight cases were elderly women.Over a long period after the diagnosis of cardiome- galy or arrhythmia, diuretics or digitalis offered good results in the treatment of edema and congestion in these patients. In view of the clinical courses included in the present study, we conclude that this disorder has a good prognosis. (Internal Medicine 38: 112-118, 1999) Key words: cardiomegaly, atrial fibrillation, elder women,good prognosis Introduction echocardiography. The severity of mitral and tricuspid regur- gitation was globally assessed by dividing into three equal parts Idiopathic enlargement of the right atrium was discussed by the distance from the valve orifice. The regurgitant jet was de- Bailey in 1955(1). This disorder may be an unusual congenital tected on color Doppler recording in the four-chamber view malformation. A review of the international literature disclosed and classified into one of the three regions (-: none, +: mild, that although several cases have been discussed since Bailey's ++:moderate, +++: severe).
    [Show full text]
  • Currentstateofknowledgeonaetiol
    European Heart Journal (2013) 34, 2636–2648 ESC REPORT doi:10.1093/eurheartj/eht210 Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Downloaded from Alida L. P. Caforio1†*, Sabine Pankuweit2†, Eloisa Arbustini3, Cristina Basso4, Juan Gimeno-Blanes5,StephanB.Felix6,MichaelFu7,TiinaHelio¨ 8, Stephane Heymans9, http://eurheartj.oxfordjournals.org/ Roland Jahns10,KarinKlingel11, Ales Linhart12, Bernhard Maisch2, William McKenna13, Jens Mogensen14, Yigal M. Pinto15,ArsenRistic16, Heinz-Peter Schultheiss17, Hubert Seggewiss18, Luigi Tavazzi19,GaetanoThiene4,AliYilmaz20, Philippe Charron21,andPerryM.Elliott13 1Division of Cardiology, Department of Cardiological Thoracic and Vascular Sciences, University of Padua, Padova, Italy; 2Universita¨tsklinikum Gießen und Marburg GmbH, Standort Marburg, Klinik fu¨r Kardiologie, Marburg, Germany; 3Academic Hospital IRCCS Foundation Policlinico, San Matteo, Pavia, Italy; 4Cardiovascular Pathology, Department of Cardiological Thoracic and Vascular Sciences, University of Padua, Padova, Italy; 5Servicio de Cardiologia, Hospital U. Virgen de Arrixaca Ctra. Murcia-Cartagena s/n, El Palmar, Spain; 6Medizinische Klinik B, University of Greifswald, Greifswald, Germany; 7Department of Medicine, Heart Failure Unit, Sahlgrenska Hospital, University of Go¨teborg, Go¨teborg, Sweden; 8Division of Cardiology, Helsinki University Central Hospital, Heart & Lung Centre,
    [Show full text]
  • Severe Acute Mitral Valve Regurgitation in a COVID-19-Infected Patient
    Case report BMJ Case Rep: first published as 10.1136/bcr-2020-239782 on 18 January 2021. Downloaded from Severe acute mitral valve regurgitation in a COVID- 19- infected patient Ayesha Khanduri, Usha Anand, Maged Doss, Louis Lovett Graduate Medical Education, SUMMARY damage leading to pulmonary oedema and respira- WellStar Health System, The ongoing SARS- CoV-2 (COVID-19) pandemic has tory failure secondary to congestive heart failure. In Marietta, Georgia, USA presented many difficult and unique challenges to the these patients, a broader differential for pulmonary medical community. We describe a case of a middle- aged oedema and respiratory failure must be considered Correspondence to to ensure timely and appropriate treatment. Dr Ayesha Khanduri; COVID-19- positive man who presented with pulmonary ayesha. khanduri@ wellstar. org oedema and acute respiratory failure. He was initially diagnosed with acute respiratory distress syndrome. CASE PRESENTATION Accepted 3 December 2020 Later in the hospital course, his pulmonary oedema and A middle-aged man presented to the emergency respiratory failure worsened as result of severe acute department with progressively worsening short- mitral valve regurgitation secondary to direct valvular ness of breath, a non-productive cough and hypox- damage from COVID-19 infection. The patient underwent emia. His medical history was significant for atrial emergent surgical mitral valve replacement. Pathological flutter status post ablation in 2017. The patient evaluation of the damaged valve was confirmed to be is a lifelong non- smoker who bikes 2 miles daily. secondary to COVID-19 infection. The histopathological At that time in 2017, an echocardiogram revealed findings were consistent with prior cardiopulmonary mild mitral valve regurgitation with a normal left autopsy sections of patients with COVID-19 described ventricular ejection fraction (LVEF >55%).
    [Show full text]
  • COVID 19 Vaccine for Adolescents. Concern About Myocarditis and Pericarditis
    Opinion COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis Giuseppe Calcaterra 1, Jawahar Lal Mehta 2 , Cesare de Gregorio 3 , Gianfranco Butera 4, Paola Neroni 5, Vassilios Fanos 5 and Pier Paolo Bassareo 6,* 1 Department of Cardiology, Postgraduate Medical School of Cardiology, University of Palermo, 90127 Palermo, Italy; [email protected] 2 Department of Medicine, University of Arkansas for Medical Sciences and the Veterans Affairs Medical Center, Little Rock, AR 72205, USA; [email protected] 3 Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy; [email protected] 4 Cardiology, Cardiac Surgery, and Heart Lung Transplantation Department, ERN, GUAR HEART, Bambino Gesu’ Hospital and Research Institute, IRCCS Rome, 00165 Rome, Italy; [email protected] 5 Neonatal Intensive Care Unit, Department of Surgical Sciences, Policlinico Universitario di Monserrato, University of Cagliari, 09042 Monserrato, Italy; [email protected] (P.N.); [email protected] (V.F.) 6 Department of Cardiology, Mater Misericordiae University Hospital and Our Lady’s Children’s Hospital Crumlin, University College of Dublin, School of Medicine, D07R2WY Dublin, Ireland * Correspondence: [email protected]; Tel.: +353-1409-6083 Abstract: The alarming onset of some cases of myocarditis and pericarditis following the adminis- tration of Pfizer–BioNTech and Moderna COVID-19 mRNA-based vaccines in adolescent males has recently been highlighted. All occurred after the second dose of the vaccine. Fortunately, none of Citation: Calcaterra, G.; Mehta, J.L.; patients were critically ill and each was discharged home. Owing to the possible link between these de Gregorio, C.; Butera, G.; Neroni, P.; cases and vaccine administration, the US and European health regulators decided to continue to Fanos, V.; Bassareo, P.P.
    [Show full text]
  • Basic Mechanisms of Myocarditis KIRK U
    Basic Mechanisms of Myocarditis KIRK U. KNOWLTON, M.D. INTERMOUNTAIN MEDICAL CENTER, SALT LAKE CITY, UTAH UNIVERSITY OF CALIFORNIA, SAN DIEGO Major mechanisms that contribute to myocarditis Infection Virus Bacteria Parasites Immune activation against infectious pathogens Innate immunity Adaptive immunity Primary immune mechanisms Myocyte injury Antigen mimicry Hypersensitivity reactions Causes of Myocarditis Checkpoint inhibitors Are there common questions between viral myocarditis and checkpoint-inhibitor mediated myocarditis? Low incidence of myocarditis in patients treated with checkpoint inhibitors A very small percentage of patients that receive checkpoint inhibitors develop myocarditis- 0.09% or 0.27% of patients treated single checkpoint inhibitors or combination checkpoint inhibitors, respectively. Low incidence of myocarditis in patients infected with viruses that are known to cause myocarditis While many patients are infected with common viruses such as Coxsackievirus, adenovirus, parvovirus, herpes virus, Epstein-Barr virus, only a very small percentage actually develop myocarditis Why? Potential genetic variants/ mutations Innate immunity Adaptive immunity Sarcolemmal membrane integrity Other factors Underlying infection Nutrition Age Pregnancy Hormones The incidence of disease is likely affected by a combination of multiple influences Therefore, Review mechanisms that have been shown to cause myocarditis And, those that increase susceptibility to myocarditis SCIENCE VOL 291 12 JANUARY 2001 Nature
    [Show full text]
  • Histopathological Characterization of Mitral Valvular Lesions from Patients with Rheumatic Heart Disease
    Artigo Original Caracterização Histológica das Lesões da Valva Mitral de Pacientes com Cardiopatia Reumática Histopathological Characterization of Mitral Valvular Lesions from Patients with Rheumatic Heart Disease Nayana F. A. Gomes,1 Marcelo A. Pascoal-Xavier,1 Livia S. A. Passos,1 Thiago Mendonça Nunes Paula,1 João Marcelo de Souza Aguiar,1 Felipe Vieira Guarçoni,1 Maria Cecília Landim Nassif,1 Claudio Leo Gelape,1 Renato Braulio,1 Paulo Henrique N. Costa,1 Luiz Guilherme Passaglia,1 Raquel Braga Martins,1 Walderez O. Dutra,1 Maria Carmo P. Nunes1 Universidade Federal de Minas Gerais,1 Belo Horizonte, MG - Brasil Resumo Fundamentos: Os mecanismos subjacentes pelos quais a doença cardíaca reumática (DCR) levam à disfunção valvar grave não são totalmente compreendidos. Objetivo: O presente estudo avaliou as alterações histopatológicas nas valvas mitrais (VM) buscando uma associação entre o padrão de disfunção valvar predominante e os achados histopatológicos. Métodos: Em 40 pacientes submetidos à troca da VM devido a DCR e em 20 controles submetidos a transplante cardíaco, foram analisados os aspectos histológicos da VM excisada. Dados clínicos e ecocardiográficos também foram coletados. As análises histológicas foram realizadas usando coloração com hematoxilina-eosina. Determinou-se inflamação, fibrose, neoangiogênese, calcificação e metaplasia adiposa. Valores de p<0,05 foram considerados estatisticamente significativos. Resultados: A idade média dos pacientes com DCR foi de 53±13 anos, sendo 36 (90%) do sexo feminino, enquanto a idade média dos controles foi de 50±12 anos, semelhante aos casos, sendo a maioria do sexo masculino (70%). O endocárdio valvar reumático apresentou espessura maior que os controles (1,3±0,5 mm versus 0,90±0,4 mm, p=0,003, respectivamente), e infiltrado inflamatório mais intenso no endocárdio (78% versus 36%; p=0,004), com predominância de células mononucleares.
    [Show full text]
  • Inflammation and Your Heart: Endocarditis, Pericarditis and Myocarditis
    Inflammation and your heart: Endocarditis, pericarditis and myocarditis Types of inflammation Myocarditis When you see the letters ‘itis’ at the end of a What causes myocarditis? Will I need treatment? word, it means inflammation. Myocarditis is inflammation of the myocardium Myocarditis is often mild and goes unnoticed, but – the heart muscle. It is usually caused by a viral, you may need to take medicines to relieve your Myocarditis, pericarditis and bacterial or fungal infection. Sometimes the cause is symptoms such as non-steroidal anti-inflammatories endocarditis refer to inflammation unknown – or ‘idiopathic’. and sometimes antibiotics. around or in the heart. If the myocarditis it is causing a problem with What are the symptoms? how well your heart pumps, you may develop the • Myocarditis – inflammation of the myocardium The symptoms of myocarditis usually include a (the heart muscle) symptoms of heart failure which you will need to pain or tightness in your chest which can spread to take several different types of medicines for. In very • Pericarditis – inflammation of the pericardium other parts of your body, shortness of breath and extreme cases where there is severe damage to the (the sac which surrounds tiredness. You may also have flu like symptoms, such heart you may be considered for a heart transplant. the heart) as a high temperature, feeling tired, headaches and aching muscles and joints. • Endocarditis – inflammation of the Inflammation of the heart often causes chest pain, endocardium (the inner lining of the heart) What tests will I need? and you may feel like you are having a heart attack. If you have not been diagnosed with one of You may need to have an electrocardiogram (ECG), these conditions and you have chest pain, or any echocardiogram (a scan of your heart similar to an of the symptoms we describe below, call 999 ultrasound) and various blood tests.
    [Show full text]